Long-Term Therapy With Ribavirin for Chronic Hepatitis C

NCT00001854 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

NIH

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Ribavirin

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)